Expression analysis of genes lying in the NF1 microdeletion interval points to four candidate modifiers for neurofibroma formation
- 11 October 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in neurogenetics
- Vol. 10 (1), 79-85
- https://doi.org/10.1007/s10048-008-0154-0
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- In vitro studies of steroid hormones in neurofibromatosis 1 tumors and schwann cellsMolecular Carcinogenesis, 2007
- PI-3-kinase-dependent membrane recruitment of centaurin-α2 is essential for its effect on ARF6-mediated actin cytoskeleton reorganisationJournal of Cell Science, 2007
- Rab11-FIP3 and FIP4 interact with Arf6 and the Exocyst to control membrane traffic in cytokinesisThe EMBO Journal, 2005
- Connective tissue dysplasia in five new patients with NF1 microdeletions: further expansion of phenotype and review of the literatureJournal of Medical Genetics, 2005
- Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 geneHuman Mutation, 2004
- Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2Journal of Medical Genetics, 2004
- Guideline to reference gene selection for quantitative real-time PCRBiochemical and Biophysical Research Communications, 2003
- SomaticNF1 mutation spectra in a family with neurofibromatosis type 1: Toward a theory of genetic modifiersHuman Mutation, 2003
- Deletions spanning the neurofibromatosis type 1 gene: Implications for genotype-phenotype correlations in neurofibromatosis type 1?Human Mutation, 1997
- An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.1993